Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-07-30Clinical Trial Update: Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
A terminated clinical trial update investigates whether genetic markers can predict response to paclitaxel in patients with newly diagnosed …
-
CLINICAL_TRIALS research · 2012-04-04Clinical Trial Update: A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
Phase II clinical trial update evaluating carboplatin with either paclitaxel or gemcitabine in platinum-sensitive, recurrent ovarian, fallop…
-
CLINICAL_TRIALS research · 2012-02-27Clinical Trial Update: Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Clinical trial update on potential biomarkers for bevacizumab-induced hypertension in patients with solid tumors; the study has been termina…
-
CLINICAL_TRIALS research · 2011-04-26Clinical Trial Update: Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating fluorouracil with or without mitomycin in patients with peritoneal cancer, includin…
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Clinical trial update examining biomarkers that may predict response to treatment in advanced ovarian epithelial cancer, fallopian tube canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-04-24Clinical Trial Update: Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers [Phase 2]
A Phase 2 trial evaluating weekly carboplatin and docetaxel in platinum-sensitive relapsed ovarian, fallopian tube, or primary peritoneal ca…